Clene, Inc. (CLNN)
3.88
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
3.98
+0.10
(+2.58%)
After-Hours: 20:00
Clene Market Cap : 49.58M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 49.58M |
| October 22, 2026 | 49.58M |
| October 21, 2026 | 48.05M |
| October 20, 2026 | 47.66M |
| October 19, 2026 | 42.04M |
| October 16, 2026 | 39.61M |
| October 15, 2026 | 42.23M |
| October 14, 2026 | 42.30M |
| October 13, 2026 | 43.32M |
| October 12, 2026 | 47.02M |
| October 09, 2026 | 49.32M |
| October 08, 2026 | 49.58M |
| October 07, 2026 | 50.09M |
| October 06, 2026 | 49.45M |
| October 05, 2026 | 49.96M |
| October 02, 2026 | 52.14M |
| October 01, 2026 | 51.37M |
| September 30, 2026 | 52.14M |
| September 29, 2026 | 52.39M |
| September 28, 2026 | 51.88M |
| September 25, 2026 | 54.95M |
| September 24, 2026 | 53.80M |
| September 23, 2026 | 54.82M |
| September 22, 2026 | 55.97M |
| September 21, 2026 | 58.01M |
| Date | Value |
|---|---|
| September 18, 2026 | 55.59M |
| September 17, 2026 | 53.03M |
| September 16, 2026 | 49.32M |
| September 15, 2026 | 51.37M |
| September 14, 2026 | 41.91M |
| September 11, 2026 | 45.62M |
| September 10, 2026 | 46.64M |
| September 09, 2026 | 47.54M |
| September 08, 2026 | 46.26M |
| September 04, 2026 | 49.20M |
| September 03, 2026 | 51.05M |
| September 02, 2026 | 53.16M |
| September 01, 2026 | 52.45M |
| August 31, 2026 | 54.69M |
| August 28, 2026 | 54.05M |
| August 27, 2026 | 57.12M |
| August 26, 2026 | 59.42M |
| August 25, 2026 | 56.74M |
| August 24, 2026 | 56.67M |
| August 21, 2026 | 55.20M |
| August 20, 2026 | 55.84M |
| August 19, 2026 | 53.54M |
| August 18, 2026 | 52.26M |
| August 17, 2026 | 53.67M |
| August 14, 2026 | 52.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.3256M |
| Brainstorm Cell Therapeutics, Inc. | 9.070M |
| Summit Therapeutics, Inc. | 12.27B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 137.67M |
Market Cap Related Metrics
| PS Ratio | 220.56 |
| PEG Ratio | -0.0315 |
| Price | 3.88 |
| Earnings Yield | -90.53% |
| PEGY Ratio | -0.0315 |